Claritev Corp Q3 FY2024 earnings call

• Travis highlighted third quarter results were within guidance, with key wins including 4 new client logos and $6.4 billion in identified potential savings. Progress on transformation included stronger relationships with Sanford Health Plan and National Rural Health Association, internal automation, refocusing data and decision science group, and positive market response to BenInsights.
• Doug discussed strong core business, cost structure assessment with potential 10%-20% cost efficiencies over years, modernizing tech platform, streamlining business structure, efficiency programs yielding tangible results like $4 million in hard savings from benefits plan, and third quarter financial results including revenues, expenses, and adjusted EBITDA.

Third quarter revenues were approximately $230.5 million, down 5.1% from Q3 2023 and 1.3% from prior quarter. Network-based revenues declined 18.8% y-o-y but were up 0.9% q-o-q. Analytics-based revenue declined 0.4% y-o-y and 1.4% q-o-q. Payment and integrity revenues decreased 3.4% y-o-y and 4.4% q-o-q. Identified potential savings for the third quarter reached $6.4 billion, a record, with core commercial health plan segment bill charges up 3% q-o-q and 11% y-o-y, and identified potential savings up 3% q-o-q and 10% y-o-y to $6 billion.

• Third quarter was within guidance range, but lower end. Expected fourth quarter to run similarly, with updated guidance ranges. Business stabilization expected in first half of 2025, with 2025 outlook to be presented on year-end earnings call in late February.

• Litigation risks related to legal claims against the company. Regulatory challenges, medical cost inflation, skilled labor shortages, provider risk, M&A consolidation, and divergence of payment rates between rural and urban providers.

Q: Joshua Raskin asked about guidance moving towards lower end and incremental changes relative to three months ago.

A: Doug Garis said volume was positive but they tightened guidance range to coalesce with current run-rate of the business.

Q: Daniel Grosslight asked about take rate degradation and future outlook.

A: Doug Garis said core business has grown consistently excluding one-client impact and COVID tailwind, and run-rate of business feels reasonable presently.

Q: Jessica Tassan asked about revenue yield mix and large customer attrition.

A: Travis Dalton said large customer attrition was a single client issue and they focus on driving organic product growth. Doug Garis said they're refreshing finance and accounting leadership for better disclosures on mix and rate.

Q: Madison Aron asked about visibility on take rate and Vision 2030 investments.

A: Doug Garis and Jerry Hogge said they'll provide detailed walk on 2025 investments and are focusing on sharpening where they put money for greater return.

Q: Joshua Kramer asked about antitrust lawsuit professional fees.

A: Doug Garis said they wouldn't share specific dollar values but manage one-time costs within core cost structure.